Sunday, September 27, 2015 9:24:22 PM
Just a quick quote from the article from the FDA
"We've also issued a draft guidance that, when final, will ENCOURAGE THE USE OF ADAPTIVE DESIGNS FOR CLINICAL TRIALS"
http://blogs.fda.gov/fdavoice/index.php/2015/09/strengthening-the-clinical-trial-enterprise-for-medical-devices-an-fdacdrh-strategic-priority-update/
Adpative Design is a key component of what Ximedica does and it is exactly what TRXC does not have. Just do a little research LTG. I can't imagine anyone who is invested in TRXC that is "LMAO".
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM